Ixensor Co Documente
Documente
0
Ticker
6734.TWO
ISIN
TW0006734007
Ixensor Co SEC Filings
Tip | Raport | Dată |
|---|---|---|
| Nu sunt disponibile documente | ||
Ixensor Co Documente 2026
Această pagină conține toate documentele oficiale și depunerile SEC pentru acțiunea Ixensor Co (6734.TWO, ISIN: TW0006734007). Aceasta include rapoarte anuale (Form 10-K), rapoarte trimestriale (Form 10-Q) și tranzacții interne (Form 4). În prezent sunt disponibile 0 documente. Datele sunt actualizate regulat pentru a oferi investitorilor o prezentare generală completă a depunerilor de reglementare ale Ixensor Co.
Ixensor Co Analiza acțiunilor
Ixensor Co iXensor Co., Ltd. generates revenue through its PixoTest Blood Glucose Monitoring System and ovulation detection system, targeting individuals managing diabetes and reproductive health. The company's technology platform measures biochemical parameters including blood sugar, luteinizing hormone, and cholesterol, providing data for diabetes management services. Its integrated medical device solutions serve customers seeking self-monitoring tools for chronic conditions and fertility tracking. The firm's products are designed for direct consumer use, with the PixoTest system offering blood glucose monitoring and the ovulation detection system supporting female hormone cycle management. These solutions leverage the company's platform to deliver personalized health insights without requiring third-party partnerships. The target segments include patients with diabetes and individuals tracking fertility cycles through biochemical monitoring.